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of human tubulo-interstitial nephntis, 480
mast-cell, basophil, IgE system (abstr.), 335
of progressive Masugi nephritis, effects of heparin on,
297
prolonged complement activation in mice, 467
of systemic lupus erythematosus (abstr.), 536
and thoracic duct drainage prior to transplantation, 5-
103
trends in immunosuppression for kidney transplantation,
S-95
urinary renal tubular antigen in tubular injury, 505
Intestinal bypass
for sorbents, S-153
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human tubulo-interstitial n., histology of, associated
with antibodies to renal basement membrane, 480
nephrotoxic serum n., immunology of, neutrophil
cationic proteins in (abstr.), 334
shunt n., basophil sensitization in (abstr.), 436
Nephrolithiasis, See also Urolithiasis
calcium oxalate and, 418
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effect of high rates of urine flow on, 201
Paracetamol
analgesic nephropathy and, 1—113
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in pre-eclampsia, 166
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Renin-angiotensin system
in normotensive patients with chronic congestive heart
failure (abstr.), 539
in study of teprotide (SQ 20881) in reducing blood
pressure, 289
Resins
for dialysate regeneration, S-138
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Tubules, renal
damage after cytostatic agents, contrast media, and
cardiac surgery, urinary indexes of (abstr.), 338
disorders in children, morphology (abstr.), 533
distal t.
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injury, urinary renal tubular antigen in, 505
leakage and obstruction after renal ischemia, structure-
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salmonella-induced infections of, (abstr.), 535
Urine
concentration and dilution, role of papillary structures at
high rates of flow, 201
hepatitis B surface antigen in, in hemodialysis patients,
327
natriuretic factor in, during water immersion, 152
parameters of, in surf-ski marathon group (abstr.), 433
Uroepithelial carcinoma
analgesic nephropathy and, 27, 34
Urolithiasis
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